Heron Therapeutics | HRTX - Fremdkapital

Aktienkurs
0.78
Täglich Wechseln
-0.04 -4.74%
Monatlich
-34.57%
Jährlich
-67.29%
Q1 Prognose
0.76




Fremdkapital Veränderung Datum
ALKERMES USD 285.82M 639K 2024-09
Alnylam Pharmaceuticals USD 2.48B 1.44B 2025-12
ANI Pharmaceuticals USD 291.84M 5.84M 2025-12
Arrowhead Research USD 538.1M 323.22M 2025-12
Eisai JPY 134.77B 12M 2025-12
Emergent BioSolutions USD 446.5M 1.7M 2023-12
Esperion Therapeutics USD 457.65M 9.5M 2025-12
GlaxoSmithKline GBP 14.71B 186M 2025-12
Heron Therapeutics USD 140.64M 975K 2025-12
Insmed USD 540.96M 1.24M 2025-12
Ligand Pharmaceuticals USD 445.49M 445.44M 2025-09
Merck USD 39.97B 6B 2025-09
Nektar Therapeutics USD 107.51M 10.35M 2024-06
Neurocrine Biosciences USD 169.5M 500K 2023-03
Omeros USD 403.72M 27.2M 2024-06
Pacira USD 372.19M 4.53M 2025-12
Regeneron Pharmaceuticals USD 2.71B 720.4M 2025-12
Roche Holding CHF 27.43B 966M 2025-12
Sangamo BioSciences USD 0 0 2022-06
Surmodics USD 29.55M 30K 2024-09
Ultragenyx Pharmaceutical USD 763.74M 19.02M 2025-09
Veracyte USD 0 0 2025-03
Vertex Pharmaceuticals USD 111.4M 1.4M 2025-03